The Legal Status of Psychedelics Around the World
In Brazil, there have been no instances of an individual being punished for the consumption, cultivation, or possession of magic mushrooms.
In Brazil, there have been no instances of an individual being punished for the consumption, cultivation, or possession of magic mushrooms.
This week in psychedelic business news: major DMT development for stroke treatment; a propriety psilocybin formulation has potential to treat obesity; two more companies join the OTC Pink Market.
They’re not quite hippies, and they’re not quite 20-year-olds on the search for existential assurance. Nope. They’re moms, and they’re coming out of the psychedelic closet to share how microdosing has helped them become better parents.
As the new industry blooms, researchers and other professionals are fighting to break down barriers to participation, information, and psychedelics themselves.
And since the classes are online, students can live anywhere in the world while taking Psychedelic and Spiritual Studies courses at the university.
“Decriminalization of entheogenic substances makes sense,” says Senator Jeff Irwin. “Let’s stop wasting time and money making more victims of the War on Drugs.”
Michelle opens up about how her work as a cannabis writer led her down the path of psychedelics, her interest in safe magic mushroom use and why she was compelled to write her guidebook Your Psilocybin Mushroom Companion.
The Vancouver-based drug development company is investigating the use of DMT as a possible treatment for stroke.
Today we are going to be talking about MindMed’s, (MNDM : NASDAQ), (MMED : NEO) patent application made in collaboration with BioXcel Therapeutics.
BioXcel is a clinical-stage biopharmaceutical company utilizing artificial intelligence approaches to develop medicines in neuroscience and immuno-oncology.
The Patent is “for detecting and preventing the early onset of agitation in patients predisposed to highly agitated behaviour”.
Enjoy the episode!
Follow us on social media! 🙌
Instagram: @thepsychedelicinvestor
Facebook: @thepsychedelicinvestor
Want to collaborate? Send us an email at:
thepsychedelicinvestor@gmail.com
Music from:
www.bensound.com
Video editing: @themyaholy
Check out our Benziga discounts
https://benzinga.grsm.io/jameshallifax1834
https://benzinga.grsm.io/thepsychedelicinvestor
DISCLAIMER: I am not a financial adviser nor a CPA. These videos are for educational and entertainment purposes only. Investing of any kind involves risk. While it is possible to minimize risk, your investments are solely your responsibility. It is imperative that you conduct your own research. I am merely sharing my opinion with no guarantee of gains or losses on investments.
All of the information in this video is public information that James (The Psychedelic Investor) believes to be reliable but it is not guaranteed to be 100% accurate and as such should not be used as advice. Any opinions or thoughts from James (The Psychedelic Investor) are subject to change.
#mindmed #mmed #mnmdstock
Steven Huang, a consultant for leading psychedelic medicine company Numinus, explains why the industry should “harness the power of diversity.”
End of content
End of content
By signing up to the Psychedelic Spotlight newsletter you agree to receive electronic communications from Psychedelic Spotlight that may sometimes include advertisements or sponsored content.